San Carlos, CA – According to filings with the U.S. Securities and Exchange Commission, Dren Bio is raising $59,999,985.00 in new funding. Sources indicate as part of senior management President, Nenad Tomasevic played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Dren Bio

Dren Bio is a biotechnology company with portfolio of attractive projects focused on powerful protein engineering technologies for depletion of cells, protein aggregates and other disease-causing agents. We are a holding company business model aimed at creating value with multiple projects as stand alone assets.

To learn more about Dren Bio, visit http://www.drenbio.com/

Contact:
Nenad Tomasevic, President
415-737-5277
https://www.linkedin.com/in/nenad-tomasevic-96b3501/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved